Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-05-30 Sale | 2025-06-02 8:55 pm | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,000 | $110.42 | $1,104,193 | 620,268 (Direct) | View |
2025-05-22 Sale | 2025-05-23 3:16 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 28,000 | $107.52 | $3,010,564 | 379,872 (Direct) | View |
2025-05-15 Sale | 2025-05-16 4:34 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 2,500 | $99.82 | $249,550 | 165,674 (Direct) | View |
2025-04-15 Sale | 2025-04-16 3:22 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 2,500 | $106.4 | $266,000 | 168,174 (Direct) | View |
2025-03-17 Sale | 2025-03-18 4:37 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 2,500 | $110.53 | $276,325 | 170,674 (Direct) | View |
2025-03-10 Sale | 2025-03-12 6:41 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 17,929 | $118.17 | $2,118,696 | 301,335 (Direct) | View |
2025-02-18 Purchase | 2025-02-20 7:42 pm | Arcus Biosciences Inc. | RCUS | GILEAD SCIENCES INC. 10% Owner | 1,363,636 | $11 | $14,999,996 | 31,424,760 (Direct) | View |
2025-02-18 Sale | 2025-02-19 4:43 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 2,500 | $104.09 | $260,225 | 169,061 (Direct) | View |
2025-02-12 Sale | 2025-02-13 9:13 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 137,676 | $102.22 | $14,073,241 | 267,667 (Direct) | View |
2025-01-31 Sale | 2025-02-03 6:09 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 142,180 | $97.22 | $13,822,740 | 234,563 (Direct) | View |
2025-01-15 Sale | 2025-01-16 3:31 pm | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 2,500 | $91.35 | $228,375 | 129,873 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-06-10 Tax Withholding | 2025-06-11 7:10 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Wilfong Diane E. Interim Corp Controller & CAO | 340 | $110.09 | 54,461 (Direct) | View |
2025-06-10 Exercise | 2025-06-11 7:10 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Wilfong Diane E. Interim Corp Controller & CAO | 920 | $0 | 54,461 (Direct) | View |
2025-06-10 Tax Withholding | 2025-06-11 7:01 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 430 | $110.09 | 68,190 (Direct) | View |
2025-06-10 Exercise | 2025-06-11 7:01 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 1,313 | $0 | 68,190 (Direct) | View |
2025-06-10 Tax Withholding | 2025-06-11 6:58 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 1,827 | $110.09 | 158,528 (Direct) | View |
2025-06-10 Exercise | 2025-06-11 6:58 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 3,843 | $0 | 158,528 (Direct) | View |
2025-06-10 Tax Withholding | 2025-06-11 6:55 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 4,968 | $110.09 | 734,648 (Direct) | View |
2025-06-10 Exercise | 2025-06-11 6:55 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,425 | $0 | 734,648 (Direct) | View |
2025-06-10 Tax Withholding | 2025-06-11 6:52 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 1,758 | $110.09 | 202,525 (Direct) | View |
2025-06-10 Exercise | 2025-06-11 6:52 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,694 | $0 | 202,525 (Direct) | View |
2025-05-22 Exercise | 2025-05-23 3:16 pm | N/A 2029-07-24 | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 25,000 | $0 | 379,872 (Direct) | View |
2025-05-22 Exercise | 2025-05-23 3:16 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 12,500 | $66.64 | 379,872 (Direct) | View |
2025-05-07 Option Award | 2025-05-08 8:26 pm | N/A 2035-05-07 | GILEAD SCIENCES INC. | GILD | Horning Sandra Director | 8,325 | $0 | 11,956 (Direct) | View |
2025-05-07 Tax Withholding | 2025-05-08 8:18 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director | 296 | $98.9 | 20,902 (Direct) | View |
2025-05-07 Option Award | 2025-05-08 8:18 pm | N/A 2035-05-07 | GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director | 8,325 | $0 | 20,902 (Direct) | View |
2025-05-07 Option Award | 2025-05-08 8:17 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Kramer Kelly A. Director | 8,325 | $0 | 25,919 (Direct) | View |
2025-05-07 Option Award | 2025-05-08 8:16 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director | 8,325 | $0 | 12,522 (Direct) | View |
2025-05-07 Option Award | 2025-05-08 6:27 pm | N/A 2035-05-07 | GILEAD SCIENCES INC. | GILD | WELTERS ANTHONY Director | 8,325 | $0 | 18,557 (Direct) | View |
2025-05-07 Option Award | 2025-05-08 6:25 pm | N/A 2035-05-07 | GILEAD SCIENCES INC. | GILD | Rodriguez Javier Director | 8,325 | $0 | 19,027 (Direct) | View |
2025-05-07 Option Award | 2025-05-08 6:22 pm | N/A 2035-05-07 | GILEAD SCIENCES INC. | GILD | LOVE TED W Director | 8,325 | $0 | 11,147 (Direct) | View |
2025-05-07 Option Award | 2025-05-08 6:20 pm | N/A 2035-05-07 | GILEAD SCIENCES INC. | GILD | BARTON JACQUELINE K Director | 8,325 | $0 | 32,865 (Direct) | View |
2025-04-25 Exercise | 2025-04-28 1:24 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 514 | $0 | 68,620 (Direct) | View |
2025-04-25 Tax Withholding | 2025-04-28 1:24 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 158 | $103.17 | 68,620 (Direct) | View |
Ownership | 2025-03-20 5:42 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Wilfong Diane E. Interim Corp Controller & CAO | 0 | $0 | 78,965 (Direct) | View |
2025-03-10 Exercise | 2025-03-12 7:15 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 8,080 | $0 | 240,488 (Direct) | View |
2025-03-10 Option Award | 2025-03-12 7:15 pm | N/A 2035-03-10 | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 60,110 | $0 | 240,488 (Direct) | View |
2025-03-10 Tax Withholding | 2025-03-12 7:15 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 3,907 | $117.21 | 240,488 (Direct) | View |
2025-03-10 Exercise | 2025-03-12 7:12 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 24,024 | $0 | 1,000,259 (Direct) | View |
2025-03-10 Option Award | 2025-03-12 7:12 pm | N/A 2035-03-10 | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 208,085 | $0 | 1,000,259 (Direct) | View |
2025-03-10 Tax Withholding | 2025-03-12 7:12 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 11,632 | $117.21 | 1,000,259 (Direct) | View |
2025-03-10 Exercise | 2025-03-12 7:08 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 3,343 | $0 | 127,074 (Direct) | View |
2025-03-10 Option Award | 2025-03-12 7:08 pm | N/A 2035-03-10 | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 41,620 | $0 | 127,074 (Direct) | View |
2025-03-10 Tax Withholding | 2025-03-12 7:08 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 1,130 | $117.21 | 127,074 (Direct) | View |
2025-03-10 Exercise | 2025-03-12 6:41 pm | N/A 2031-03-10 | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 25,897 | $0 | 301,335 (Direct) | View |
2025-03-10 Exercise | 2025-03-12 6:41 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 17,929 | $63.91 | 301,335 (Direct) | View |
2025-03-10 Option Award | 2025-03-12 6:41 pm | N/A 2035-03-10 | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 60,110 | $0 | 301,335 (Direct) | View |
2025-03-10 Tax Withholding | 2025-03-12 6:41 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,855 | $117.21 | 301,335 (Direct) | View |
2025-03-10 Exercise | 2025-03-12 6:10 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 1,952 | $0 | 49,328 (Direct) | View |
2025-03-10 Tax Withholding | 2025-03-12 6:10 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 624 | $117.21 | 49,328 (Direct) | View |
2025-03-10 Option Award | 2025-03-12 6:04 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer | 46,240 | $0 | 95,215 (Direct) | View |
2025-02-12 Exercise | 2025-02-13 9:13 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 26,175 | $57.92 | 267,667 (Direct) | View |
2025-02-12 Exercise | 2025-02-13 9:13 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 18,210 | $83.49 | 267,667 (Direct) | View |
2025-02-12 Exercise | 2025-02-13 9:13 pm | N/A 2031-03-10 | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 137,676 | $0 | 267,667 (Direct) | View |
2025-02-12 Exercise | 2025-02-13 9:13 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 77,691 | $63.91 | 267,667 (Direct) | View |
2025-02-12 Exercise | 2025-02-13 9:13 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 15,600 | $80.72 | 267,667 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:24 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 709 | $0 | 37,787 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:21 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 12,371 | $0 | 34,011 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:18 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 224,504 | $0 | 617,876 (Direct) | View |
2025-02-04 Tax Withholding | 2025-02-06 4:18 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 108,156 | $97.99 | 617,876 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:14 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 90,505 | $0 | 119,979 (Direct) | View |
2025-02-04 Tax Withholding | 2025-02-06 4:14 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 45,666 | $97.99 | 119,979 (Direct) | View |
2025-02-04 Option Award | 2025-02-06 4:11 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 84,488 | $0 | 171,223 (Direct) | View |
2025-02-04 Tax Withholding | 2025-02-06 4:11 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 43,138 | $97.99 | 171,223 (Direct) | View |
2025-01-31 Exercise | 2025-02-03 6:09 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 44,160 | $65.38 | 234,563 (Direct) | View |
2025-01-31 Exercise | 2025-02-03 6:09 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 26,170 | $57.92 | 234,563 (Direct) | View |
2025-01-31 Exercise | 2025-02-03 6:09 pm | N/A 2032-03-10 | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 142,180 | $0 | 234,563 (Direct) | View |
2025-01-31 Exercise | 2025-02-03 6:09 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 71,850 | $72.34 | 234,563 (Direct) | View |
2025-01-25 Exercise | 2025-01-27 5:47 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 515 | $0 | 49,519 (Direct) | View |
2025-01-25 Tax Withholding | 2025-01-27 5:47 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 187 | $93.07 | 49,519 (Direct) | View |
2025-01-02 Option Award | 2025-01-03 6:38 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Berger Dietmar Chief Medical Officer | 48,975 | $0 | 48,975 (Direct) | View |